X-ray structures are now available for more than 60 ligands and 20 GPCRs.
Structures reveal details of ligand biding that could not be predicted.
Structure-based drug design for GPCRs has been transformed by the new results.
Lipophilic sites and water molecules have key roles in ligand-binding properties.